Visceral leishmaniasis infection during adalimumab therapy: a case report and literature review

MeSH terms

• Adalimumab
• Aged
• Amphotericin B / therapeutic use
• Antibodies, Monoclonal, Humanized / adverse effects*
• Antiprotozoal Agents / therapeutic use
• Antirheumatic Agents / adverse effects*
• Arthritis, Rheumatoid / diagnosis
• Arthritis, Rheumatoid / drug therapy*
• Arthritis, Rheumatoid / immunology
• Bone Marrow Examination
• Drug Substitution
• Glucocorticoids / therapeutic use
• Humans
• Immunocompromised Host
• Leishmaniasis, Visceral / chemically induced*
• Leishmaniasis, Visceral / diagnosis
• Leishmaniasis, Visceral / drug therapy
• Leishmaniasis, Visceral / immunology
• Leishmaniasis, Visceral / parasitology
• Male
• Methylprednisolone / therapeutic use
• Predictive Value of Tests
• Risk Factors
• Treatment Outcome